# Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans

> **NCT06845358** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** BCG TICE strain
- **OTHER:** Sodium Chloride, 0.9%
- **OTHER:** Sterile Water for Injection

## Key facts

- **NCT ID:** NCT06845358
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-11-26
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study not implemented due to funding.
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06845358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06845358, "Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06845358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*